This strategic partnership with WuXi XDC represents a major milestone for Akari and a powerful validation of our novel PH1 payload technology,” said Abizer Gaslightwala, President and Chief Executive ...
Edinburgh News on MSN
Edinburgh scientists launch £1.5m study to 'sabotage' bowel cancer cells
A new Edinburgh-based Cancer Research UK-funded study hopes to find a way to ‘sabotage’ bowel cancer cells.
New research shows how muscular dystrophy (DM1) damages the heart over time, stressing the need for early diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results